background


Product Information:

GS-5718

Edecesertib (GS-5718) is a selective, potent, orally active IRAK-4 inhibitor. Edecesertib has anti-inflammatory activity. Edecesertib can be used for rheumatoid arthritis (RA) and lupus erythematosus (LE) research.

Cat. No.: EX-A9060    Purity: >98%
Chemical
Chemical structure of GS-5718


For research only, Do not use for Human!

SizeUnit Price (US$)StockQuantityOrder
100mg2900In-stock
250mg3800In-stock
500mg4880In-stock
1g6680In-stock


SynonymsEdecesertib
Synonyms 2GS5718
CAS No.2408839-73-4
Purity>98%
FormulaC22H22FN7O2
Mol Weight435.4542
AppearanceLight yellow to yellow solid
SolubilitySoluble in DMSO
Shelf Life>3 years if stored properly
StoragePowder 4℃, sealed storage, away from moisture and light, 2 years; In solvent -20℃ 1 month;
ShippingShipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
 
 
Reference:  

[1]. Roedder S, et, al. Phase 1 Study Results of GS-5718, an Oral IRAK4-Inhibitor: Pharmacodynamics of Single and Multiple Doses of GS-5718 in Healthy Subjects. 2021 Nov 6.

[2]. WHO Drug Information. International Nonproprietary Names for Pharmaceutical

[3]. Feng Y, et al. Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer[J]. Acta Pharmaceutica Sinica B, 2024.

[4]. Kurochkina Y, et al. POS0673 TOLEROGENIC DENDRITIC CELLS IN RHEUMATOID ARTHRITIS PATIENTS: NEWS AND PROMISES[J]. 2021.

[5]. Kalliolias GD, et al. Targeting TLR Signaling Cascades in Systemic Lupus Erythematosus and Rheumatoid Arthritis: An Update. Biomedicines. 2024 Jan 9;12(1):138.

[6]. Ammann S, et al., Pyrrolo[1,2-b] pyridazine derivatives. WO2020014468A1.

CoACoA of GS-5718

KEYWORDS: buy GS-5718 | GS-5718 supplier | purchase | cost | manufacturer | order | distributor | buy 2408839-73-4 | 2408839-73-4 supplier